Adaptive Radiotherapy in Patients With Gynecological Tumors
Recruiting
N/A
Interventional Study
Gynecological Tumor
Adaptive Radiotherapy
Radiation
Curative Treatment
Optimization
Adaptive Radiation Therapy
Image Guided Radiotherapy
Cervical Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- University Hospital, Essen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prospective randomized evaluation of adaptive radiotherapy in the definitive radiotherapy of locally advanced gynecologic carcinoma (e.g. cervical carcinoma, endometrial carcinoma, vaginal carcinoma), in the postoperative situation or first series of external beam radiotherapy and in patients in whom radical surgery or HDR brachytherapy as dose boost is not an option.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
ECOG 0-1 confirmation by histophatology MR of the pelvis staging
Exclusion Criteria:
Recurrent disease Prior Radiotherapy in pelvic region stage pM1 or cM1
Contacts
No contact information available.